For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...

Patients with some gastrointestinal tumors were able to be treated with immunotherapy drugs alone and avoid surgery, ...

UCLA researchers demonstrated that a novel topical BRAF inhibitor gel called LUT014 significantly reduces the severity of an acne-like rash, a common and painful side effect experienced by patients ...

PD-1 and PD-L1 inhibitors are types of immune checkpoint inhibitors, which are immunotherapy ... mild to severe. Certain side effects may negatively affect a person’s outlook. A cancer care ...

LUT014, a BRAF inhibitor gel, improved acne-like rashes in patients with colorectal cancer undergoing anti-EGFR therapy, ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical BRAF inhibitor gel called LUT014 ...

In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as ...

A new clinical trial shows the immunotherapy ... being cancer-free after two years. For the most part, the side effects of dostarlimab were mild and included symptoms such as fatigue or rash.

Neoadjuvant PD-1 blockade with dostarlimab achieved high rates of organ preservation in patients with early-stage mismatch ...

In a groundbreaking cancer study, researchers found that immunotherapy drugs alone can treat gastrointestinal tumours.For as ...